3.4 Read 9 reviews
Overview
This Nucleic Acid Therapeutics - Existing and Emerging Approaches for Managing and Treating Diseases course offered by Harvard Medical School Online explores nucleic acid therapeutics and their growing role in the prevention and treatment of disease. Participants examine therapeutic approaches that remove, modify, or introduce genetic information within patient cells, with a focus on addressing conditions for which conventional medicines provide limited solutions. The programme highlights the mechanisms, applications, and challenges associated with this rapidly evolving area of biomedical innovation.
Key Facts
Learners investigate antisense oligonucleotides, small interfering RNA therapies, messenger RNA medicines, immunostimulatory nucleic acids, and gene-editing technologies. The course examines delivery challenges, safety considerations, vector-based approaches, and therapeutic applications through examples including Duchenne muscular dystrophy, sickle cell disease, and melanoma. Participants also explore permanent genetic modification strategies and the scientific principles supporting emerging treatment platforms.
Programme Structure
Topics include:
- Antisense Oligonucleotide (ASO) Therapeutics
- ASO Gapmer Therapeutics
- siRNA Therapeutics
- Exon Inclusion and Exon Exclusion Strategies
- mRNA Medicines
- mRNA Vaccines
- mRNA Therapeutic Vaccines
- Immunostimulatory Nucleic Acids
- Nucleic Acid-Based Immunotherapy
Key information
Duration
- Part-time
- 3 months
Start dates & application deadlines
- Starting
- Apply before
-
- Starting
- Apply before
-
Language
English
Delivered
Online
- Semi-structured
Campus Location
- Boston, United States
Disciplines
Genetics View 8 other Short Courses in Genetics in United StatesWhat students do after studying
Join for free or log in to access our complete career info list.
Academic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
This course builds on foundational science by exploring complex concepts through engaging biomedical visualizations, clinical applications, and real-world scenarios. Participants are recommended to have prior knowledge of basic biology, genetics, and chemistry to gain the greatest benefit from the material.
- The course is suitable for clinicians and other medical professionals seeking insight into recent advances in nucleic acid therapeutics and their application to diseases previously considered untreatable. It is also appropriate for biomedical researchers, academics, and professionals working in genetics and related fields, as well as individuals in the biopharmaceutical industry who require an understanding of the unique properties of nucleic acid therapeutics in comparison with other therapeutic approaches.
Tuition Fees
Tuition fees are shown in and the most likely applicable fee is shown based on your nationality.
-
International Applies to you
Applies to youNon-residents1025 USD / full≈ 1025 USD / full - Out-of-State1025 USD / full≈ 1025 USD / full
-
Domestic
Applies to youIn-State1025 USD / full≈ 1025 USD / full
Funding
Improve page content